AVKARE Inc. recalls Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski,
Recalled March 27, 2019 · FDA recall D-1044-2019 · AVKARE
Hazard
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified · FDA Class II
Units
N/A
Sold at
Nationwide.
Description
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Product
Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15
Manufacturer(s)
AVKARE Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →